STABLECOIN DEVELOPMENT CORP
SDEVNYSE AMERICAN🏆 #3581 by market capEarnings Nov 5US Equity
$1.04▲ $0.02 (+1.96%)
Market closed · at close1h—
24h▲ 2.0%
7d▼ 0.5%
14d▼ 8.8%
30d▼ 14.8%
1y▼ 65.4%
🏦Market Cap
$52M
Small Cap
📈Revenue Growth (YoY)
-74.7%
Declining
📊Gross Margin
54.6%
Healthy
💵FCF Margin
36.3%
Strong
⚖️P/S Ratio
2.0x
Cheap
Otter Score
49
Weak
Trading Snapshot
- Day Range
- $1.02 – $1.06
- 52-Week Range
- $0.96 – $99.75
- Volume
- $1.83B
- Avg Volume
- $1.59B
- Shares Outstanding
- 50.5M
- Next Earnings
- Sep 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $26M
- Last Q Revenue
- $2M
- P/E Ratio
- 0.1
- P/S Ratio
- 2.0x
- EPS (TTM)
- $-0.76
- Dividend Yield
- —
Why Investors Own SDEV
- ✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 35% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$26M▲ +48.6% YoY
Gross Margin (TTM)
34.6%▲ +2.8% YoY
Operating Income (TTM)
$8M▲ +48.6% YoY
Free Cash Flow (TTM)
$7M▲ +48.6% YoY
About STABLECOIN DEVELOPMENT CORP
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
49/100
Analyst Ratings
ⓘConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2025